Deals
J&J New CEO’s Takeover Watch Spans Edwards to St. Jude: Real M&A
This article is for subscribers only.
Johnson & Johnson’s pursuit of growth through acquisitions could put companies from Edwards Lifesciences Corp. to St. Jude Medical Inc. on its wish list.
A year after J&J announced the biggest acquisition in its 126-year history, newly appointed Chief Executive Officer Alex Gorsky is now looking to takeovers to bolster the medical-device unit with products such as heart valves, according to an interview last week with Bloomberg News. J&J’s own cardiovascular sales have fallen for five straight years, the only business in its medical device division to shrink.